Syntegra
Syntegra is a San Francisco-based seed-stage company that uses generative AI to produce privacy-preserving synthetic healthcare datasets, serving healthcare and life sciences organizations for AI model training, medical research, drug discovery, and clinical trial design.
- Company typePrivate
- Founded2019
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Syntegra does
Syntegra is a privately held, seed-stage company founded in 2019 and headquartered in San Francisco that applies machine learning and generative AI to produce synthetic healthcare datasets. The core product — branded "Healthcare Data Synthetic Solutions" — is a pre-trained model that generates artificial patient-level datasets mirroring the statistical properties of real-world healthcare data, enabling downstream AI training, medical research, drug discovery, medical image analysis, workflow automation, and clinical trial design without exposing sensitive patient information.
The technical approach is presented as generative AI-based synthetic data generation with an emphasis on preserving data utility for research while eliminating privacy risks. Marketing language explicitly asserts compliance with HIPAA, GDPR, and CCPA, and the company describes its differentiator as domain specialization in healthcare rather than generic synthetic-data tooling. The product was commercialized in January 2022, supported by a $5.625 million seed round led by WVV Capital in August 2020 with broad syndicate participation (Berkeley Catalyst Fund, First Spark Ventures, GRID Ventures, Hike Ventures, Impact Venture Capital, Innovation Global Capital, Launchpad Capital, Sweat Equity Ventures, Vastly Valuable Ventures, Village Global).
Commercially, Syntegra targets a single vertical — healthcare and life sciences — with pain points centered on data privacy, regulatory compliance, and limited access to real patient data for AI development. The revenue model is described as subscription or recurring, but no pricing, contract structures, ARR, or named customers are disclosed. The GTM motion is characterized as product-led with direct enterprise and partnership-led outreach to research and provider organizations, and the company is actively building collaborations across healthcare, technology, and data privacy domains. Headcount sits in the 11-50 range; leadership includes founder/CEO Michael Lesh, co-founder/CTO Ofer Mendelvitch, Head of Growth Carter Prince, and Head of Strategy and Business Operations Arthur Copstein.
Syntegra firmographics
Firmographics- Name
- Syntegra
- Website
- https://syntegra.io
- Company type
- Private
- Founded year
- 2019
- Headcount range
- 11–50 employees
- Short description
- Syntegra is a San Francisco-based seed-stage company that uses generative AI to produce privacy-preserving synthetic healthcare datasets, serving healthcare and life sciences organizations for AI model training, medical research, drug discovery, and clinical trial design.
- Ownership category
- akta.pro rank
Syntegra industry classification
Industry- Product category
- Synthetic Healthcare Data Platform
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Synthetic Data Generation Platforms (HDAAALAA)
- akta.pro secondary industry
- Domain-Specific Training Data Solutions (e.g., medical, AV, geospatial) (HDAAALAL)
Keywords
Where Syntegra is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Markets served
Syntegra business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- Synthetic Healthcare Data Solutions: Commercializing synthetic healthcare data solutions for AI model training and research purposes. As a seed-stage company, the specific revenue mechanics are not yet publicly disclosed.
Go-to-market motion1 record
Syntegra product offering
Product offeringCore offering
Syntegra applies state-of-the-art machine learning models to generate synthetic healthcare datasets that mirror the statistical properties of real-world patient data while preserving privacy and ensuring compliance with HIPAA, GDPR, and CCPA. The pre-trained synthetic data models are used for AI model training, medical research, drug discovery, and clinical trial design optimization, allowing healthcare organizations to develop and validate AI without accessing sensitive patient information.
Product overview
Syntegra offers healthcare data synthetic solutions powered by generative AI. The company provides a pre-trained model that generates synthetic healthcare data for research and AI development purposes. The core product enables organizations to create privacy-compliant artificial datasets while maintaining the statistical properties of original healthcare data.
Differentiator
Problem solved
Functional benefit
Products and services
- Healthcare Data Synthetic Solutions AI-powered synthetic data generation platform that creates privacy-preserving artificial healthcare datasets from real-world data, enabling research and AI development without exposing sensitive patient information. Designed for healthcare organizations, life sciences companies, and research institutions that need compliant training data for AI model development, drug discovery, and clinical trial design.
Quantifiable outcome
- Synthetic healthcare data enables AI model training while maintaining HIPAA/GDPR compliance
Companies that use Syntegra
Customer profileSegments1 record
Ideal customer profiles1 record
Syntegra technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature1 record
Syntegra partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Healthcare CollaboratorsdevelopingSyntegra is building collaborations in healthcare, technology, and data privacy sectors. The seed funding will support growth in these collaborations, though specific named partners have not been disclosed.
Scale indicators2 records
Recent moves5 records
Expansion highlights5 records
Syntegra competitors and assessment
Company assessmentDirect peers
- MDClone: MDClone generates synthetic healthcare data for research and analytics without exposing real patient records. Direct competitor to Syntegra in the privacy-preserving healthcare synthetic data space, serving similar hospital and life sciences customers.
- Gretel.ai: Gretel provides a developer-focused synthetic data platform with APIs for generating synthetic text, tabular, and time-series data, including healthcare use cases. Direct competitor on synthetic data generation technology, though Gretel is horizontal rather than healthcare-specialized.
- Tonic.ai: Tonic.ai offers synthetic data generation and de-identification primarily for software development and testing, with extensions into healthcare and regulated industries. Competes with Syntegra on synthetic data tooling, though Tonic's strongest footprint is in dev/test data rather than clinical research.
- Mostly AI: Mostly AI provides a synthetic data platform for tabular data including financial services and healthcare. Direct competitor in synthetic data generation, with comparable privacy-preserving positioning to Syntegra but broader vertical reach.
- Hazy: Hazy is an enterprise synthetic data platform focused on financial services with expanding healthcare applications. Competes with Syntegra on generative synthetic data technology, particularly for structured tabular datasets.
Broad incumbents
- Datavant: Datavant is a large, well-capitalized health data connectivity platform that has expanded into de-identified and synthetic data offerings for healthcare and life sciences. Much broader portfolio than Syntegra, but overlaps directly on enabling privacy-preserving health data access.
- AWS (HealthLake / Bedrock synthetic data): AWS provides HealthLake and Bedrock-based services that include capabilities relevant to healthcare data management and synthetic data generation at scale. As a hyperscaler, AWS represents both a potential partner and a bundling threat to standalone synthetic data vendors like Syntegra.
- IQVIA: IQVIA is a large CRO and healthcare data analytics provider with proprietary de-identified and synthetic patient datasets used for clinical research and commercial analytics. Competes with Syntegra at the buyer level for synthetic data in life sciences R&D.
Emerging players
- Synthesis AI: Synthesis AI focuses on synthetic data for computer vision, with less direct healthcare overlap. Adjacent competitor in the broader synthetic data ecosystem relevant to AI model training.
- TripleBlind: TripleBlind offers privacy-preserving data collaboration tools for healthcare AI, including synthetic data and federated learning. Partially overlapping with Syntegra on privacy-preserving healthcare data for AI development.
Market position
Strengths1 record
Weaknesses1 record
Competitive moat2 records
Key risks6 records
Key highlights6 records
Customer concentration
Syntegra social profiles
Digital presenceSyntegra financial estimates
Financial estimateRevenue estimate
Valuation estimate
Syntegra leadership team
Management profileNumber of profiles
Profiles4 records
Syntegra funding detail
Funding detailFunding overview
Funding rounds2 records
Investors12 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Syntegra M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Syntegra
What does Syntegra do?
Syntegra applies state-of-the-art machine learning models to generate synthetic healthcare datasets that mirror the statistical properties of real-world patient data while preserving privacy and ensuring compliance with HIPAA, GDPR, and CCPA. The pre-trained synthetic data models are used for AI model training, medical research, drug discovery, and clinical trial design optimization, allowing healthcare organizations to develop and validate AI without accessing sensitive patient information.
When was Syntegra founded?
Syntegra was founded in 2019. It employs 11 to 50 people.
Where is Syntegra based?
Syntegra is headquartered in San Francisco, United States, in the North America region.
How does Syntegra make money?
One revenue line is on record: synthetic Healthcare Data Solutions.
Who are Syntegra's main competitors?
Direct peers on record are MDClone, Gretel.ai, Tonic.ai, Mostly AI and Hazy. Broad incumbents are Datavant, AWS (HealthLake / Bedrock synthetic data) and IQVIA. Emerging players are Synthesis AI and TripleBlind.
Does Syntegra have an API?
No public API is recorded for Syntegra.
What industry is Syntegra in?
Syntegra's product category is Synthetic Healthcare Data Platform. Its primary akta.pro industry code is HDAAALAA, Synthetic Data Generation Platforms, with a secondary code of HDAAALAL, Domain-Specific Training Data Solutions (e.g., medical, AV, geospatial). Its NAICS code is 54171 and its SIC code is 7372.